Metabolomic profiling of urine-derived extracellular vesicles from rat model of drug-induced acute kidney injury.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
26 03 2021
Historique:
received: 20 01 2021
accepted: 23 01 2021
pubmed: 14 2 2021
medline: 18 5 2021
entrez: 13 2 2021
Statut: ppublish

Résumé

Extracellular vesicles (EVs) are lipid bilayer particles that are released by various cells and provide a real-time snapshot of the state of these cells in tissue in a noninvasive manner. EVs contain components, including mRNA, miRNAs, proteins, and metabolites. Therefore, EVs hold promise for the discovery of liquid biopsy-based biomarkers for disease diagnosis. In the present study, metabolome analysis of urine EVs in rats with kidney injury caused by cisplatin and puromycin aminonucleoside was performed using liquid chromatography/mass spectrometry to identify candidate biomarkers that reflect the type and extent of injury in drug-induced nephrotoxicity. A total of 396 metabolites were detected in urine EVs, of which 65 were identified as potential biomarkers in urine EVs of drug-induced nephrotoxicity. Pathway analysis revealed that these metabolites may reflect changes occurring within damaged cells during kidney injury, suggesting that metabolomics of urine EVs could be a useful informative tool.

Identifiants

pubmed: 33581383
pii: S0006-291X(21)00141-8
doi: 10.1016/j.bbrc.2021.01.082
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-110

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Masayoshi Saito (M)

DMPK Research Laboratories, Mitsubishi Tanabe Pharma Corporation, Yokohama, Kanagawa, 227-0033, Japan; Laboratory of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. Electronic address: saitou.masayoshi@mx.mt-pharma.co.jp.

Satoshi Horie (S)

DMPK Research Laboratories, Mitsubishi Tanabe Pharma Corporation, Yokohama, Kanagawa, 227-0033, Japan.

Hidenori Yasuhara (H)

DMPK Research Laboratories, Mitsubishi Tanabe Pharma Corporation, Yokohama, Kanagawa, 227-0033, Japan.

Akane Kashimura (A)

Safety Research Laboratories, Mitsubishi Tanabe Pharma Corporation, Fujisawa, Kanagawa, 251-8555, Japan.

Eiji Sugiyama (E)

Laboratory of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.

Takeaki Saijo (T)

DMPK Research Laboratories, Mitsubishi Tanabe Pharma Corporation, Yokohama, Kanagawa, 227-0033, Japan.

Hajime Mizuno (H)

Laboratory of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.

Hiroshi Kitajima (H)

DMPK Research Laboratories, Mitsubishi Tanabe Pharma Corporation, Yokohama, Kanagawa, 227-0033, Japan.

Kenichiro Todoroki (K)

Laboratory of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. Electronic address: todoroki@u-shizuoka-ken.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH